NOVNQ vs. NOVN, STAB, VRAYQ, AHPI, HGEN, GNCA, ARAV, CNTX, GRFS, and LVTX
Should you be buying NVN Liquidation stock or one of its competitors? The main competitors of NVN Liquidation include Novan (NOVN), Statera Biopharma (STAB), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Humanigen (HGEN), Genocea Biosciences (GNCA), Aravive (ARAV), Context Therapeutics (CNTX), Grifols (GRFS), and LAVA Therapeutics (LVTX). These companies are all part of the "medical" sector.
Novan (NASDAQ:NOVN) and NVN Liquidation (NASDAQ:NOVNQ) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, community ranking, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.
In the previous week, Novan had 1 more articles in the media than NVN Liquidation. MarketBeat recorded 1 mentions for Novan and 0 mentions for NVN Liquidation. NVN Liquidation's average media sentiment score of 0.00 equaled Novan'saverage media sentiment score.
14.5% of Novan shares are held by institutional investors. 1.3% of Novan shares are held by insiders. Comparatively, 1.3% of NVN Liquidation shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Novan received 239 more outperform votes than NVN Liquidation when rated by MarketBeat users.
NVN Liquidation has a net margin of 0.00% compared to NVN Liquidation's net margin of -128.61%. Novan's return on equity of 0.00% beat NVN Liquidation's return on equity.
Novan has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, NVN Liquidation has a beta of 1.73, meaning that its share price is 73% more volatile than the S&P 500.
Summary
NVN Liquidation beats Novan on 5 of the 9 factors compared between the two stocks.
Get NVN Liquidation News Delivered to You Automatically
Sign up to receive the latest news and ratings for NOVNQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NOVNQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NOVNQ vs. The Competition
NVN Liquidation Competitors List
Related Companies and Tools
